Back
Experian PLC Vs. Cidara Therapeutics Industry Stock Comparison
Buy
61
EXPGF
Experian PLC
Last Price:
$53.50
Seasonality Move:
2.94%
Buy
72
CDTX
Cidara Therapeutics
Last Price:
$50.58
Seasonality Move:
-8.55%
Buy
61
Experian PLC (EXPGF)
is a Buy
Is Experian PLC a Buy, Sell or Hold?
-
The current Experian PLC [EXPGF] share price is $53.50. The Score for EXPGF is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
EXPGF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
72
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
-
The current Cidara Therapeutics [CDTX] share price is $50.54. The Score for CDTX is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EXPGF Stock Price Chart
What is Experian PLC's stock price today?
-
The Experian PLC share price today is $53.50Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EXPGF is experiencing slight buying pressure.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $50.54Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight buying pressure.
EXPGF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 11.9 | Buy |
Relative Strength Index (14 RSI): | 77.48 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (50.78 - 52.58) | Buy |
Bollinger Bands (100): | (45.69 - 51.79) | Buy |
CDTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.75 | Buy |
Relative Strength Index (14 RSI): | 77.36 | Buy |
Chaikin Money Flow: | 24640 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.19 - 50.39) | Buy |
Bollinger Bands (100): | (16 - 35.28) | Buy |
EXPGF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 52.74 | Buy |
20-day SMA: | 51.86 | Buy |
50-day SMA: | 51.28 | Buy |
200-day SMA: | 48.53 | Buy |
8-day EMA: | 33.92 | Buy |
20-day EMA: | 17.65 | Buy |
50-day EMA: | 7.91 | Buy |
200-day EMA: | 2.1 | Buy |
CDTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.6 | Buy |
20-day SMA: | 40.9 | Buy |
50-day SMA: | 30.03 | Buy |
200-day SMA: | 21.62 | Buy |
8-day EMA: | 49.1 | Buy |
20-day EMA: | 42.88 | Buy |
50-day EMA: | 33.88 | Buy |
200-day EMA: | 23.66 | Buy |
Experian PLC Earnings Growth & EXPGF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.76 per share, and a decrease next year of $0.53 per share.
Experian PLC Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cidara Therapeutics Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |